Dermisonics, Inc. (DMSI)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0010 - Volume
800 - Avg. Volume
800 - Market Cap (intraday)
1,575 - Beta (5Y Monthly) -235.30
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4410 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.
--
Full Time Employees
September 30
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: DMSI
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DMSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DMSI
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-12.06%
Return on Equity (ttm)
-392.24%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-22.59M
Diluted EPS (ttm)
-0.4410
Balance Sheet and Cash Flow
Total Cash (mrq)
22.77k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
97.57k
Company Insights: DMSI
DMSI does not have Company Insights